PatrickA.CambierMD

PubMed

• 72 citations
  A Randomized Comparison of a Novel Bioabsorbable Vascular Closure Device Versus Manual Compression in the Achievement of Hemostasis After Percutaneous Femoral Procedur...
  S. Chiu Wong, William Bachinsky, Patrick A. Cambier, Robert C. Stoler, Janah Aji, Jason H. Rogers, James B. Hermiller, Ravi Nair, Herbert Hutman, Hong Wang, Eclipse Tr...> ;JACC. Cardiovascular Interventions. 2009 Aug 1
• 2 citations
  Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from ...
  Jiro Aoki, Gary S. Mintz, Neil J. Weissman, Lazar Mandinov, Eberhard Grube, Keith D. Dawkins, Stephen G. Ellis, Joel Greenberg, Alan Yu, J. Tift Mann, Louis Cannon, Pa...> ;The American Journal of Cardiology. 2008 Oct 15
• 45 citations
  Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TA...
  Neil J. Weissman, Stephen G. Ellis, Eberhard Grube, Keith D. Dawkins, Joel Greenberg, Tift Mann, Louis Cannon, Patrick Cambier, Stephen Fernandez, Gary S. Mintz, Lazar...> ;European Heart Journal. 2007 Jul 1
• 28 citations
  Safety and Efficacy of the 2.25-mm Sirolimus-Eluting Bx Velocity Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: the SIRIUS 2.25 Trial
  Jeffrey W. Moses, Eugenia Nikolsky, Roxana Mehran, Patrick A. Cambier, William Bachinsky, Fred Leya, Richard E. Kuntz, Jeffrey J. Popma, Patricia A. Schleckser, Hong W...> ;The American Journal of Cardiology. 2006 Dec 1
• 22 citations
  Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: Results from the FIRE trial
  Amir Halkin, A.R. Zaki Masud, Campbell Rogers, James B. Hermiller, Robert L. Feldman, Patrick Hall, Robert Haber, Patrick A. Cambier, Ron P. Caputo, Mark Turco, Richar...> ;American Heart Journal. 2006 Apr 1
• 2 citations
  Influence of vessel diameter on the efficacy of distal protection devices during saphenous vein graft intervention
  Aravind Swaminathan, Gregg W. Stone, Campbell Rogers, James B. Hermiller, Robert L. Feldman, Patrick Hall, Robert Haber, A.R. Zaki Masud, Patrick A. Cambier, Ronald P....> ;The American Journal of Cardiology. 2005 Mar 1
• 267 citations
  Randomized Comparison of Distal Protection With a Filter-Based Catheter and a Balloon Occlusion and Aspiration System During Percutaneous Intervention of Diseased Saph...
  Gregg W. Stone, Campbell Rogers, James B. Hermiller, Robert Feldman, Patrick Hall, Robert Haber, A. Masud, Patrick A. Cambier, Ron P. Caputo, Mark Turco, Richard Kovac...> ;Circulation. 2003 Aug 5
• 14 citations
  Efegatran sulfate as an adjunct to streptokinase versus heparin as an adjunct to tissue plasminogen activator in patients with acute myocardial infarction
  Anthony Fung, Gerald Lorch, Patrick A. Cambier, D.Dennis Hansen, Bradley G. Titus, Jenny S. Martin, Jennifer J. Lee, Nathan R. Every, Alfred P. Hallstrom, Donna Stock-...> ;American Heart Journal. 1999 Oct 1
• 16 citations
  Coronary steal by IMA bypass graft side‐branches: A novel therapeutic use of a new detachable embolization coil
  Michael D. Eisenhauer, David M. Mego, Patrick A. Cambier> ;Catheterization and Cardiovascular Diagnosis. 1998 Nov 1
• 14 citations
  Bedside videoscopic placement of feeding tubes : Development of fiberoptics through the tube
  Kurt W. Grathwohl, Robert V. Gibbons, Thomas A. Dillard, John D. Horwhat, Bernard J. Roth, James W. Thompson, Patrick A. Cambier> ;Critical Care Medicine. 1997 Apr 1
• 11 citations
  Late coronary aneurysm formation after directional atherectomy
  Kerry C. Prewitt, John R. Laird, Patrick A. Cambier, Dale C. Wortham> ;American Heart Journal. 1993 Jan 1
• 223 citations
  Percutaneous closure of the small (< 2.5 mm) patent ductus arteriosus using coil embolization
  Patrick A. Cambier, William C. Kirby, Dale C. Wortham, John W. Moore> ;The American Journal of Cardiology. 1992 Mar 15
• Treatment of prosthetic tricuspid valve thrombosis with recombinant tissue-type plasminogen activator.
  Cambier, P., Mombaerts, P., De Geest, H., Collen, D., Van De Werf, F.> ;Eur Heart J. 1987 Aug
• Pharmacokinetics and thrombolytic properties of a nonglycosylated mutant of human tissue-type plasminogen activator, lacking the finger and growth factor domains, in d...
  Cambier, P., van de Werf, F., Larsen, G. R., Collen, D.> ;J Cardiovasc Pharmacol. 1988 Apr
• Join now to see all

Journal Articles

• Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents  
  Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, Holmes DR Jr, Krucoff MW, Hermiller J, Dauerman HL..., N Engl J Med, 1/4/2014
• Treatment of anemia with darbepoetin alfa in systolic heart failure  
  Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, Maggioni AP, McMurray JJ, O'Connor C, Pfeffer MA, Solomon SD, Sun Y, Tendera M, van Veldhuisen DJ; RED-HF Co..., N Engl J Med, 1/28/2013
• Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)  
  McMurray JJ, Anand IS, Diaz R, Maggioni AP, O'Connor C, Pfeffer MA, Solomon SD, Tendera M, van Veldhuisen DJ, Albizem M, Cheng S, Scarlata D, Swedberg K, Young JB; RED..., Eur J Heart Fail, 1/1/2013
• Effects of dalcetrapib in patients with a recent acute coronary syndrome  
  Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah P..., N Engl J Med, 1/29/2012
• Contrast medium-induced acute kidney injury: comparison of intravenous and intra-arterial administration of iodinated contrast medium  
  Karlsberg RP, Dohad SY, Sheng R; Iodixanol Peripheral Computed Tomographic Angiography Study Investigator Panel, J Vasc Interv Radiol, 1/1/2011
• Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome  
  Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mat..., Am Heart J, 1/1/2009
• A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after percutaneous femoral procedur...  
  Wong SC, Bachinsky W, Cambier P, Stoler R, Aji J, Rogers JH, Hermiller J, Nair R, Hutman H, Wang H; ECLIPSE Trial Investigators, JACC Cardiovasc Interv, 1/1/2009
•  
  Stephen G. Ellis, Louis A. Cannon, Tift Mann, Patrick A. Cambier, Charles D. O’Shaughnessey, Samuel DeMaio, Patrick Hall, Eric R. Powers, Takahiro Uchida, Keith D. Daw..., Transcatheter Cardiovascular Therapeutics, 1/1/2009
• Three Year Clinical Results from the TAXUS V de novo Trial: Long-term safety and Efficacy of the Paclitaxel-Eluting TAXUS Stent in Complex Lesions  
  Ellis, S., Cannon, L., Cambier, P. et al, American Journal of Cardiology, 1/20/2007
• Results from the 225 mm Sirolimus-eluting BX Velocit Stent Registry in Patients with Native Coronary Artery Lesions, Drug eluting Stents II  
  Eugenia Nikolsky, Jeffery W Moses, Patrick Cambier, Transcatheter Cardiovascular Therapeutics, 1/1/2005
• Impact of High versus Low Pressure Stent Implantation Techniques on 30-Day and 9-Month Outcomes in the TAXUS V Trial, Drug Eluting Stents I  
  Patrick A. Cambier, Transcatheter Cardiovascular Therapeutics, 1/1/2005
• Vascular Closure after Diagnostic Cardiac Catheterization with VasoStasis: A Novel That Leaves Nothing Behind in the femoral Artery Vascular Access  
  H.H. Ting, H.W. Chambers, P.A. Cambier, R.K. Sharma, Transcatheter Cardiovascular Therapeutics, 1/1/2004
• Impact of Vessel Size on Outcomes of Different Distal Protection Devices During Saphenous Vein Graft Intervention: a FIRE Trial Sub-Study  
  Cambier, P, Swaminathan, Aravind, Herrmann, H, C, Rogers, C, Hermiller, J, Feldman, R, Hall, P., American College of Cardio, 1/1/2004
• Results of Intervention in Ostial and Nonostial Saphenous Vein Graft Lesions Using Different Distal Protection Devices The FIRE Trial Distal Protection devices During...  
  A.Z. Masud, C. Rogers, J. Hermiller, R. Feldman, P. Hall, R. Haber, R. Kovach, P. Cambier, Transcatheter Cardiovascular Therapeutics. American Journal of Cardiology, 1/1/2003
• Impact of Transcient Flow Reduction on the efficacy of Embolic Protection Filters: Results from the FIRE Trial Distal Protection devices During Saphenous Vein Graft I...  
  J.B. Hermiller, A. Masud, D. Cox, R. Feldman, P. Hall, P. Cambier, Transcatheter Cardiovascular Therapeutics, 1/1/2003
• The FIRE Trial: 30Day and 6-Moth Results of a Multicenter Randomized /trial Comparing distal Protection with the FilterWire EX and GuardWire During Saphenous Vein Graf...  
  A.Z. Masud, J. Hermiller, R. Feldman, P. Hall, R. Haber, P.A. Cambier, Transcatheter Cardiovascular Therapeutics, 1/1/2003
• Stenting in Saphenous Vein Grafts with distal Protection Using the Second Generation FilterWire EZ: The BLAZE Registry Distal Protection devices During Saphenous Vei...  
  Patrick A. Cambier, D. Cox, A. Masud, F. Myers, R. Kovach, P. Cambier, 1/1/2003
• Efegatran Sulfate as an Adjunct to Streptokinases Versus Heparin as a Patient with Acute Myocardial Infarction  
  Fung, Anthony Y. MB, BS; Lorch, Gerald MD; Cambier, P. MD, American Heart Journal, 1/1/1999
• Coronary Steal by IMA Bypass raft Side-Branches: A Novel Therapeutic Use a New Detachable Embolization Coil  
  Eisenhauer M, Cambier P, Mego D., Cathet Cardiovasc Diagn., 1/1/1999
• Beneficial Impact of Aortocoronary Bypass Graft Markers  
  Eisenhauer M, Cambier P, Collier E., Cathet Cardiovasc Diagn., 1/1/1998
• Bedside COMMENT: Thick horizontal line Insert category text after the commentVideoscopic Placement of Feeding Tubes: Development of a Through the Tube Technique  
  Grathwohl K, Gibbons R, Roth B, Dillard T, Thompson J, Cambier P, J.Inten.Care, 1/1/1997
• Efegatran and Streptokinase vs TPA and Heparin for Treatment of Acute Myocardial Infarction  
  Weaver W.D., Fung A, Lorch G, Cambier P, Hansen D, Titus B, Prince C, Henderson M, Scherer J, Every N, Circulation, 1/1/1996
• Transcatheter Closure of the Persistently Patent Ductus Arteriosus  
  Moore J., Cambier P, J Interven Cardiol, 1/1/1995
• Improved Safety of Transcatheter Vascular Occlusion Utilizing a New Retrievable Coil Device  
  Cambier P, Stajduhar K, Powell D, Gomez R, Virmani R, Farb A, Moore J, J Am Coll Cardiol, 1/1/1994
• Percutaneous Closure of The Small Ductus Arteriosus Using Occluding Spring Coils  
  Moore J, George L, Kirkpatrick S, Mathewson J, Cambier P, et al, J Am Coll Cardiol, 1/1/1994
• Join now to see all

Lectures

• Parachute Ventricular Partitioning device 
  Orlando, FL - 1/1/2015
• Impact of High versus Low Pressure Stent Implantation Techniques on 30-Day and 9-Month Outcomes in the TAXUS V Trial, Drug Eluting Stents I 
  1/1/2005
• Choice of Interventional Device Based on Lesion Morphology and Clinical Presentation 
  1/1/1996
• Transcatheter Occlusion Utilizing a New Detachable Coil Device: Initial Clinical Results 
  1/1/1995
• Evolving Techniques of Transcatheter Occlusion of the Persistently Patent Ductus Arteriosus 
  1/1/1995
• Influence of Variable Inflation (Oscillation) on Angioplasty Balloon Deformation and Dilating Force 
  1/1/1994
• Improved Safety of Transcatheter Vascular Occlusion Using a New Retrievable Coil Device 
  1/1/1994
• Transcatheter Revascularization of Dysfunctional Dialysis Access: Results and Long-term Follow Up 
  1/1/1992
• Successful Percutaneous Closure of the Persistently Patent Ductus Arteriosus Using Coil Embolization 
  1/1/1991
• Long-term Transesophageal Assessment of Mitral Valve Repair 
  1/1/1990
• Objective Benefit of Diltiazem in Raynaud's Phenomenon, A Double-Blind Crossover Study 
  1/1/1989
• Join now to see all